here we come .We it â€™s not just Shkreli and Turing similar instances of extreme    just within the last year , have been seen in the pharma companies Mylan and Valeant .   To be sure , compared to the industry as a whole , those smaller companies the pharma companies Mylan and Valeant outliers .   However , according to an August 2016 article in the Journal of the American Medical Association , the problem of high prices is , indeed , systemic :   Per capita prescription drug spending in the United States exceeds that in all other countries , largely driven by    drug prices that have been increasing in recent years at rates far beyond the consumer price index .   